You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Several tumor types eligible

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumors, Cerebral Aneurysm, Cerebral Arteriovenous Malformation Trial in Seoul (AR-based navigation)

Recruiting
  • Brain Neoplasms
  • +3 more
  • AR-based navigation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 8, 2023

Colorectal Cancer Trial in Sohag

Recruiting
  • Colorectal Cancer
    • Sohag, Egypt
      Faculty of Medicine
    Oct 27, 2022

    Kaposi Sarcoma Trial run by the NCI (Abemaciclib)

    Recruiting
    • Kaposi Sarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Solid Tumor, Adult
    • CD70-targeting CAR-T cells
    • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 8, 2023

    Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Lymphoma
    • CD70-targeting CAR-T cells
    • Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 9, 2023

    Acceptance Processes, Rejection, Psychology Trial in Alexandria (Virtual Reality-Enhanced Gagne's Instructional Model)

    Completed
    • Acceptance Processes
    • Rejection, Psychology
    • Virtual Reality-Enhanced Gagne's Instructional Model
    • Alexandria, Please Select A Country, Egypt
    • +1 more
    Nov 17, 2023

    Liver Diseases, Liver Transplantation Trial (Partial hepatectomy (open approach), liver transplantation, Portal vein

    Recruiting
    • Liver Diseases
    • Liver Transplantation
    • Partial hepatectomy (open approach)
    • +2 more
    • Villejuif, Val De Marne, France
      Centre Hépato-Biliaire - Hôpital Paul Brousse
    Jan 16, 2023

    Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Copper-64 labeled Granzyme B (64Cu-GRIP B)
    • Positron Emission Tomography (PET)
    • San Francisco, California
      University of California, San Francisco
    Jun 7, 2023

    Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

    Recruiting
    • Malignant Solid Neoplasms
    • Nilotinib (400 mg BID)
    • +6 more
    • Bordeaux, France
    • +6 more
    Dec 15, 2022

    Colorectal Cancer Trial in Worldwide (Regorafenib, Atezolizumab, Imprime PGG)

    Recruiting
    • Colorectal Cancer
    • Duarte, California
    • +17 more
    Aug 3, 2022

    Tumor Vaccines for Solid Tumors

    Recruiting
    • Glioma
    • Solid Tumor
    • tumor vaccine
    • +3 more
    • Shanghai, Shanghai, China
      Huashan Hospital, Fudan University
    Oct 22, 2023

    Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

    Recruiting
    • Advanced Biliary Tract Carcinoma
    • Pembrolizumab Injection [Keytruda]
    • Lenvatinib Mesylate
    • Shanghai, Shanghai, China
    • +1 more
    Jul 19, 2022

    Other Forms of Epilepsy, Treatment Resistant Trial in Elche (Cathodal tDCS)

    Completed
    • Other Forms of Epilepsy, Treatment Resistant
    • Cathodal tDCS
    • Elche, Alicante, Spain
      Spanish Foundation for Neurometrics Development
    Apr 10, 2023

    Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

    Recruiting
    • Cryoglobulinemic Vasculitis (CV)
    • +9 more
      • Los Angeles, California
      • +7 more
      Jan 12, 2023

      A Screening Study Targeting Tumor-specific Antigens

      Recruiting
      • Metastatic Colorectal Cancer
      • Stage II/III Colon Cancer
      • blood collection for research (next generation sequencing [NGS])
      • +2 more
      • Los Angeles, California
      • +6 more
      Dec 2, 2021

      Tumors Trial in Chengdu

      Recruiting
      • Neoplasms
        • Chengdu, Sichuan, China
          Departments of Nuclear Medicine, Sichuan Provincial People's Hos
        Oct 16, 2023

        Tumors Trial in France (Blood and tumor samples)

        Recruiting
        • Neoplasms
        • Blood and tumor samples
        • Annecy, France
        • +5 more
        Apr 8, 2022

        NSCLC Trial in United States (erlotinib, bemcentinib)

        Completed
        • Non-Small Cell Lung Cancer
        • Los Angeles, California
        • +9 more
        Aug 16, 2022

        Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

        Not yet recruiting
        • Small Cell Lung Cancer (SCLC)
        • +3 more
        • (no location specified)
        Dec 7, 2022

        Rapid Autopsy and Procurement of Cancer Tissue

        Recruiting
        • Thymus Tumors
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 20, 2022

          Childhood Brain Tumor Trial in Saint Louis (Neurocognitive testing, rsfcMRI)

          Recruiting
          • Childhood Brain Tumor
          • Neurocognitive testing
          • rsfcMRI
          • Saint Louis, Missouri
            Washington University School of Medicine
          Apr 5, 2022

          Gastric Adenocarcinoma, Pancreas Adenocarcinoma, Gastric Tumor Trial (PT886)

          Not yet recruiting
          • Gastric Adenocarcinoma
          • +2 more
          • (no location specified)
          Aug 10, 2022

          Solid Tumors Trial in Worldwide (RO7296682, Atezolizumab)

          Recruiting
          • Solid Tumors
          • Duarte, California
          • +12 more
          Jan 31, 2023

          Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

          Recruiting
          • Brain Cancer
          • [18F]fluoro-2-deoxy-D-glucose (FDG)
          • +3 more
          • Salt Lake City, Utah
            Huntsman Cancer Institute
          Jan 3, 2023

          Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

          Terminated
          • Head and Neck Cancer
          • +7 more
          • Tumor Profiling
          • Scottsdale, Arizona
          • +2 more
          Dec 2, 2022